Company page

Emergent Biosolutions Inc.

Emergent Biosolutions Inc. (EBS) is a public company based in the United States, focusing on providing solutions for public health threats. With a market capitalization of approximately $416.4 million, the company is engaged in developing and manufacturing vaccines and therapeutics. Emergent aims to address critical health challenges through its innovative products and services.